Lu Yongkai, Xu Jiaxin, Liu Siyan, Tian Baochun, Long Feng
School of Chemistry and Life Resources, Renmin University of China, Beijing, 100872, China.
Beijing Daxing Xinkang Hospital, Beijing, 102600, China.
Mikrochim Acta. 2024 Dec 6;192(1):9. doi: 10.1007/s00604-024-06865-5.
A novel hybridization chain reaction (HCR) powered optical fiber-embedded microfluidic biochip (HCR-FMB) has been constructed for ultrafast and sensitive detection of lethal-7a (let-7a) in serum. By integrating HCR, fluorescence energy resonant transfer, and evanescent wave fluorescence principle, the HCR-FMB enables detecting let-7a with satisfactory limit of detection of 100.0 pM within 6 min at room temperature, and demonstrates excellent specificity. The HCR-FMB can directly detect let-7a in serum with high sensitivity and without any pre-treatment, and good recoveries were observed for let-7a in serum samples, demonstrating their potential application to the analysis of serum samples. The HCR-FMB exhibits several advantages, including rapidity, enzyme-free, miniaturization, ease-of-operation, field-deployment applicability, minimal-equipment, and cost-effectiveness. The HCR-FMB can be considered a revolutionary detection device that rapidly adapts and deploys in various settings, especially in low medical resource regions.
一种新型的基于杂交链式反应(HCR)的光纤嵌入式微流控生物芯片(HCR-FMB)已被构建出来,用于超快速、灵敏地检测血清中的致死-7a(let-7a)。通过整合HCR、荧光能量共振转移和倏逝波荧光原理,HCR-FMB能够在室温下6分钟内以100.0 pM的满意检测限检测let-7a,并表现出优异的特异性。HCR-FMB能够直接高灵敏度地检测血清中的let-7a,无需任何预处理,血清样本中let-7a的回收率良好,证明了其在血清样本分析中的潜在应用价值。HCR-FMB具有多种优势,包括快速、无需酶、小型化、操作简便、适用于现场部署、设备需求少以及成本效益高。HCR-FMB可被视为一种革命性的检测设备,能够在各种环境中快速适应和部署,特别是在医疗资源匮乏的地区。